The study of outcome, quality of life and cost-effectiveness in glaucoma patients receiving trabeculectomy versus medicatio
Not Applicable
- Conditions
- Moderate to advanced glaucomaGlaucomaCost effectivenessTrabeculectomyMedicationQuality of life
- Registration Number
- TCTR20160215001
- Lead Sponsor
- ็Health systems research institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 118
Inclusion Criteria
1. Newly diagnosed (within 3 months) glaucoma which is one of the followings: primary open angle glaucoma or pseudo exfoliation glaucoma or primary angle closure glaucoma that was underwent laser iridotomy and had visible trabecular meshwork at least 180 degrees.
2. Initial intraocular pressure at least 20 mmHg
3. Visual field mean deviation less than -6 dB
4. Able to have regular follow up schedule
Exclusion Criteria
1. history of any intraocular surgery except for uncomplicated phacoemulsification with IOL for more than 3 months.
2. active intraocular inflammation
3. history of eye trauma
4. current or anticipated (in 1 year) pregnancy
5. allergy to sulfonamide
6. uncooperated patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure 1 year Goldman tonometer
- Secondary Outcome Measures
Name Time Method quality of life 1 year NEI-VEQ25,cost effectiveness 1 year EQ5D5